Brooks Lab.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
67.29
-0.12 (-0.18%)
BSENSE

Nov 20

BSE+NSE Vol: 70.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
19.25
22.96
20.21
16.57
23.45
25.51
23.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
19.25
22.96
20.21
16.57
23.45
25.51
23.32
Raw Material Cost
9.10
13.68
11.81
9.08
10.42
13.62
15.37
Purchase of Finished goods
0.09
0.14
0.03
1.49
3.00
2.41
0.03
(Increase) / Decrease In Stocks
2.02
-1.14
0.57
-1.57
0.29
-0.13
0.41
Employee Cost
4.16
4.21
3.85
3.72
3.93
3.67
3.38
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
3.56
4.20
3.26
3.12
3.29
2.83
2.58
Total Expenditure (Excl Depreciation)
18.93
21.09
19.53
15.84
20.93
22.39
21.77
Operating Profit (PBDIT) excl Other Income
0.32
1.87
0.68
0.73
2.52
3.12
1.55
Other Income
0.98
0.18
0.44
0.13
0.39
0.22
0.62
Operating Profit (PBDIT)
1.30
2.05
1.12
0.86
2.91
3.34
2.17
Interest
0.25
0.21
0.09
0.16
0.28
0.30
0.26
Exceptional Items
74.70
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
75.75
1.84
1.03
0.70
2.63
3.04
1.91
Depreciation
0.45
0.42
0.41
0.39
0.39
0.39
0.39
Profit Before Tax
72.93
-1.79
1.52
5.50
7.98
9.58
-1.28
Tax
5.32
0.00
0.00
0.00
0.00
0.00
0.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.99
1.42
0.61
0.30
2.24
2.65
1.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.99
1.42
0.61
0.30
2.24
2.65
1.34
Share in Profit of Associates
-2.38
-3.21
0.91
5.20
5.74
6.93
-2.80
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
67.61
-1.79
1.52
5.50
7.98
9.58
-1.46
Equity Capital
29.46
29.46
29.46
29.46
29.46
29.46
29.46
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
22.95
-0.61
0.52
1.87
2.71
3.25
-0.5
Diluted Earnings per share
22.95
-0.61
0.52
1.87
2.71
3.25
-0.54
Operating Profit Margin (Excl OI)
1.66%
8.14%
3.36%
4.41%
10.75%
12.23%
6.65%
Gross Profit Margin
393.51%
8.01%
5.1%
4.22%
11.22%
11.92%
8.19%
PAT Margin
351.22%
-7.8%
7.52%
33.19%
34.03%
37.55%
-6.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is -16.16% vs 13.61% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 3,877.09% vs -217.76% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is -82.89% vs 175.00% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 19.05% vs 133.33% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Brooks Lab. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
19.25
25.33
-6.08
-24.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
19.25
25.33
-6.08
-24.00%
Raw Material Cost
9.10
12.09
-2.99
-24.73%
Purchase of Finished goods
0.09
0.00
0.09
(Increase) / Decrease In Stocks
2.02
0.50
1.52
304.00%
Employee Cost
4.16
2.47
1.69
68.42%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
3.56
3.80
-0.24
-6.32%
Total Expenditure (Excl Depreciation)
18.93
18.85
0.08
0.42%
Operating Profit (PBDIT) excl Other Income
0.32
6.48
-6.16
-95.06%
Other Income
0.98
0.10
0.88
880.00%
Operating Profit (PBDIT)
1.30
6.58
-5.28
-80.24%
Interest
0.25
0.39
-0.14
-35.90%
Exceptional Items
74.70
0.00
74.70
Gross Profit (PBDT)
75.75
6.19
69.56
1,123.75%
Depreciation
0.45
0.66
-0.21
-31.82%
Profit Before Tax
72.93
5.53
67.40
1,218.81%
Tax
5.32
1.38
3.94
285.51%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
69.99
4.15
65.84
1,586.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
69.99
4.15
65.84
1,586.51%
Share in Profit of Associates
-2.38
0.00
-2.38
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
67.61
4.15
63.46
1,529.16%
Equity Capital
29.46
12.28
17.18
139.90%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
22.95
3.38
19.57
578.99%
Diluted Earnings per share
22.95
3.38
19.57
578.99%
Operating Profit Margin (Excl OI)
1.66%
25.58%
0.00
-23.92%
Gross Profit Margin
393.51%
24.44%
0.00
369.07%
PAT Margin
351.22%
16.38%
0.00
334.84%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.25 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -16.16% vs 13.61% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -17.91% vs 12.79% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 67.61 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3,877.09% vs -217.76% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 747.24% vs 301.52% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.32 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -82.89% vs 175.00% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -87.30% vs 66.89% in Sep 2025

Quarterly - Interest
Interest 0.25 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 19.05% vs 133.33% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -10.71% vs -12.50% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.66%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025